Search hospitals > North Carolina > Durham

Durham VA Medical Center, Durham, NC

Claim this profile
Durham, North Carolina 27705
Global Leader in Lung Cancer
Global Leader in Post-Traumatic Stress Disorder
Conducts research for Prostate Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
335 reported clinical trials
42 medical researchers
Photo of Durham VA Medical Center, Durham, NC in DurhamPhoto of Durham VA Medical Center, Durham, NC in DurhamPhoto of Durham VA Medical Center, Durham, NC in Durham

Summary

Durham VA Medical Center, Durham, NC is a medical facility located in Durham, North Carolina. This center is recognized for care of Lung Cancer, Post-Traumatic Stress Disorder, Prostate Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Durham VA Medical Center, Durham, NC is involved with conducting 335 clinical trials across 334 conditions. There are 42 research doctors associated with this hospital, such as Michael J. Kelley, Rhonda Bitting, MD, Scott Shofer, and David Edelman, MD MHS.

Area of expertise

1Lung Cancer
Global Leader
Durham VA Medical Center, Durham, NC has run 42 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Post-Traumatic Stress Disorder
Global Leader
Durham VA Medical Center, Durham, NC has run 34 trials for Post-Traumatic Stress Disorder.

Top PIs

Clinical Trials running at Durham VA Medical Center, Durham, NC

Lung Cancer
Prostate Cancer
Post-Traumatic Stress Disorder
Non-Small Cell Lung Cancer
Cancer
Traumatic Stress Disorders
Small Cell Lung Cancer
Traumatic Brain Injury
Tumors
Multiple Myeloma
Image of trial facility.

Chemotherapy + Immunotherapy vs. Immunotherapy

for Advanced Lung Cancer

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Image of trial facility.

Sotorasib

for Non-Small Cell Lung Cancer

This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Durham VA Medical Center, Durham, NC?
Durham VA Medical Center, Durham, NC is a medical facility located in Durham, North Carolina. This center is recognized for care of Lung Cancer, Post-Traumatic Stress Disorder, Prostate Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. Durham VA Medical Center, Durham, NC is involved with conducting 335 clinical trials across 334 conditions. There are 42 research doctors associated with this hospital, such as Michael J. Kelley, Rhonda Bitting, MD, Scott Shofer, and David Edelman, MD MHS.
Where is Durham VA Medical Center, Durham, NC located?
Directions to Durham VA Medical Center: From I-85, take exit 172 for Durham Freeway South (Route 147). Follow signs for Duke and VA Medical Centers to exit 15 (Fulton Street). Turn right at the bottom of the exit ramp and continue approximately 1/4 mile; the Durham VA Medical Center will be on your right.
Who should I call to ask about financial aid or insurance network?
**Durham VA Medical Center - Financial Assistance and Insurance Departments** - **Main Phone Number:** 919-286-0411 - **Copay Balance Inquiries:** For questions regarding your VA health care bill's copay balance, please call the toll-free number provided. - **In-Person Payments:** Visit the Agent Cashier Window in Room F1194, 1st floor. Open Monday through Friday, 8:00 a.m. to 4:30 p.m.
What insurance does Durham VA Medical Center, Durham, NC accept?
The Durham VA Medical Center in Durham, North Carolina, accepts a wide range of insurance plans. These include commercial health insurance plans such as Aetna, Blue Cross Blue Shield of North Carolina, CIGNA Healthcare of NC, Humana, Optima Health, Progyny, and United Healthcare. Additionally, exchange health insurance through Healthcare.gov (Cigna Healthcare of NC), governmental health insurance plans like Medicare Advantage Plans, Medicaid Managed Care (NC plans only), and National Transplant Networks (Aetna Institutes of Excellence, Blue Distinction Centers for Transplant, CIGNA LifeSource Transplant Network, and Humana National Transplant Network) are accepted.
What awards or recognition has Durham VA Medical Center, Durham, NC received?
The Durham VA Medical Center, located in Durham, North Carolina, is renowned for its contributions to health services research, evidenced by the Research Career Scientist Award (RCS). It is integral to the Cooperative Studies Program Epidemiology Center (CSPEC)-Durham, a key player among six national epidemiology centers dedicated to population-based research. Additionally, the center is supported by the Institute for Medical Research, which focuses on enhancing the health and lives of veterans, their families, and the public through research and education.